Choi, Bum Chae
Zhou, Canquan
Ye, Hong
Sun, Yun
Zhong, Ying
Gong, Fei
Sini, Ivan
Abramova, Nadezda
Longobardi, Salvatore
Hickey, Miranda
D’Hooghe, Thomas
Funding for this research was provided by:
Merck KGaA (N/A)
Article History
Received: 19 February 2021
Accepted: 20 December 2021
First Online: 17 January 2022
Declarations
:
: The study received approval and was carried out in accordance with the recommendations of the 18th World Medical Assembly (Helsinki, 1964) and all applicable amendments. The study was conducted in compliance with International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use-Good Clinical Practice (ICH-GCP E6, 1996), and the applicable national regulations. The eligible patients signed written informed consent forms prior to participation in the study.
: Not applicable.
: NA, SL, TDH, and MH are employees of Merck Healthcare KGaA, Darmstadt, Germany. BCC, CZ, HY, YS, YZ, FG, and IS have no conflicts of interest to declare.